“Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq””, J. Can. Res. Updates, vol. 15, no. 1, pp. 150–155, Jun. 2026, doi: 10.30683/1929-2279.2026.15.13.